bioAffinity Technologies, Inc. (BIAF) Q4 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to the BioAffinity Technologies fourth quarter 2022 financial results conference call. All participants will be in listen-only mode. Should you need assistance, please signal conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded I'd like to turn the conference over to Julianne Overton, Director of Corporate Communications. Please go ahead. Thank you, Operator. Good morning, everyone, and welcome to today's conference call to discuss BioAffinity Technologies' fourth quarter and full year 2022 financial results and our recent business progress. Please note that certain information discussed during today's call is covered under the Safe Harbor provisions. of the Private Securities Litigation Reform Act. We caution listeners that BioAuthenticity Technologies Management will be making forward-looking statements and that actual results may differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. These risks and uncertainties are detailed in and are qualified by the cautionary statements contained in BioAuthenticity Technologies press releases, and SEC filing. This conference call contains time-sensitive information that is accurate only as of the date of the live broadcast today, April 3rd, 2023. BioAffinity Technologies undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as required by law. I would lik...